Schonfeld Strategic Advisors »

Novabay Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Novabay Pharmaceuticals shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 15k 1.49

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Novabay Pharmaceuticals

BlackRock
Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Jane Street
Two Sigma Investments
State of Wyoming
Schonfeld Strategic Advisors
Catalyst Funds Management Pty
Hrt Financial
Vanguard Global Advisers
Wells Fargo & Company
UBS Group
Morgan Stanley
NVWM

View all funds holding Novabay Pharmaceuticals